Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score
Circulating PENK offers incremental value for predicting in-hospital AKI and mortality in ACS. The simple six-item KID-ACS risk score integrates PENK and provides a novel tool for simultaneous assessment of renal and mortality risk in patients with ACS.
Authors
- Christian Templin (ORCID: https://orcid.org/0000-0003-0287-4193)
- Stefano Ministrini (ORCID: https://orcid.org/0000-0003-4358-6411)
- Jiří Pařenica (ORCID: https://orcid.org/0000-0003-1065-8351)
- Oliver Hartmann (ORCID: https://orcid.org/0000-0002-5663-645X)
- Janet-Jacqueline Olic
- Francesco Bruno (ORCID: https://orcid.org/0000-0003-0019-0273)
- Arnold von Eckardstein (ORCID: https://orcid.org/0000-0002-1666-2266)
- Florian Kahles (ORCID: https://orcid.org/0000-0001-6343-2562)
- Andreas Bergmann (ORCID: https://orcid.org/0000-0002-4466-1682)
- Florian A. Wenzl (ORCID: https://orcid.org/0000-0001-6654-9918)
- Lorenz Räber (ORCID: https://orcid.org/0000-0003-0824-3026)
- Simon Kraler (ORCID: https://orcid.org/0000-0002-8245-7287)
- Victor Schweiger (ORCID: https://orcid.org/0009-0008-9361-8817)
- Jiří Jarkovský (ORCID: https://orcid.org/0000-0002-1400-0111)
- Slayman Obeid
- Kok Weng Ow (ORCID: https://orcid.org/0000-0002-2729-6863)
- Giovanni G. Camici (ORCID: https://orcid.org/0000-0002-0523-0695)
- Mattia Arrigo (ORCID: https://orcid.org/0000-0003-4028-2869)
- Marco Roffi (ORCID: https://orcid.org/0000-0002-3051-0170)
- Olivier Müller (ORCID: https://orcid.org/0000-0003-2441-5799)
- Donald J. L. Jones (ORCID: https://orcid.org/0000-0001-6583-870X)
- Luca Liberale (ORCID: https://orcid.org/0000-0003-1472-7975)
- Tomáš Ondrúš (ORCID: https://orcid.org/0000-0002-6621-0364)
- Alexander Akhmedov (ORCID: https://orcid.org/0000-0003-3052-9493)
- Alexandre Mebazaa (ORCID: https://orcid.org/0000-0001-8715-7753)
- Jatinderpal K. Sandhu (ORCID: https://orcid.org/0000-0002-5612-274X)
- Thong Huy Cao (ORCID: https://orcid.org/0000-0002-6559-0836)
- Luboš Bouček (ORCID: https://orcid.org/0009-0000-6226-0471)
- Leong L. Ng (ORCID: https://orcid.org/0000-0002-6553-5749)
- Peizhi Wang (ORCID: https://orcid.org/0000-0002-5769-6171)
- Andreas Schober (ORCID: https://orcid.org/0000-0001-8491-3840)
- Fabian Lang (ORCID: https://orcid.org/0000-0003-2890-029X)
- Daniel Tarnwski
- Alexander Schober
- Carsten Jungbauer
- Thomas F. Lüscher
Institutions
- University of Leicester (GB)
- Inserm (FR)
- King's College - North Carolina (US)
- King's College London (GB)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- University of Zurich (CH)
- Université Paris Cité (FR)
- Masaryk University (CZ)
- University Hospital of Bern (CH)
- Glenfield Hospital (GB)
- University Hospital of Basel (CH)
- Harefield Hospital (GB)
- Karolinska Institutet (SE)
- University Hospital Regensburg (DE)
- Sorbonne Paris Cité (FR)
- Fondazione Ricerca Molinette (IT)
- Royal Brompton Hospital (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- University Hospital of Zurich (CH)
- Lung Institute (US)
- University Hospital Brno (CZ)
- Molecular Partners (Switzerland) (CH)
- University Hospital of Geneva (CH)
- Hôpital Lariboisière (FR)
- King's College School (GB)
- Universitätsklinikum Aachen (DE)
- Institute of Health Information and Statistics (CZ)
- Stadtspital Waid (CH)
- Ospedale Policlinico San Martino (IT)
- Hengyang Academy of Agricultural Sciences (CN)
- National Cancer Registration Service (GB)
- Fu Wai Hospital (CN)
- Hospital Base (CL)
- NIHR Leicester Biomedical Research Centre (GB)
- Imperial College London (GB)
- University of Genoa (IT)
- University of Lausanne (CH)
Publication Details
- Journal
- European Heart Journal
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1093/eurheartj/ehae602
- Citations
- 12
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.82
Funders
- National Science Foundation
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Foundation for Cardiovascular Research
- Novartis Foundation
- Boston Scientific Corporation
- Regeneron Pharmaceuticals
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- National Institute for Health and Care Research
- British Heart Foundation
- Bayer HealthCare
- European Society of Cardiology
- European Foundation for the Study of Diabetes
- Deutsche Forschungsgemeinschaft
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Bundesministerium für Bildung und Forschung
- Ministerstvo Zdravotnictví Ceské Republiky
- Novo Nordisk
- Schweizerische Herzstiftung
- China Scholarship Council
- Novartis Stiftung für Medizinisch-Biologische Forschung
- Deutsche Herzstiftung
- Universität Zürich
- Karl-Franzens-Universität Graz
- Medizinische Universität Graz
- Servier
- Sphingotec GmbH
- European Research Area Network on Cardiovascular Diseases
- Merck Sharp and Dohme
- NIHR Sheffield Biomedical Research Centre
- Daiichi Sankyo Europe